Literature DB >> 25088494

Association of baseline dyslipidemia with stroke recurrence within five-years after ischemic stroke.

Emre Kumral1, Dilek Evyapan, Figen Gökçay, Bedriye Karaman, Mehmet Orman.   

Abstract

BACKGROUND AND
PURPOSE: The association between dyslipidemia (DL) and stroke recurrence is unclear, but may be influenced by different subtypes of stroke. This study aims to explore whether DL contributes to the recurrence of certain subtypes of ischemic stroke.
METHODS: Data from the Ege Stroke Registry was examined, and five-years follow-up data for stroke recurrence was analyzed. Trial of Org 10172 in Acute Stroke Treatment criteria was used to classify the subtypes of all stroke. Recurrent stroke was defined as a new neurological deficit compatible to ischemic stroke or intracerebral hemorrhage. The association between DL and stroke recurrence in patients with different sroke subtypes was analyzed using univariable and multivariable logistic regression models. Survival curves were estimated with Kaplan-Meier methods, and survival analyses were undertaken using Cox proportional hazards models.
RESULTS: Of the 9940 patients with ischemic stroke, 5838 (58·7%) had DL and 2202 (22·2%) experienced a stroke recurrence within five-years. The frequency of stroke recurrence of patients with DL was unsignificantly higher than those without at five-years of follow-up (18·0% vs. 17·0%; P = 0·21). After stratification by Trial of Org 10172 in Acute Stroke Treatment subtypes, multivariable analysis revealed a significant association between DL and stroke recurrence in all ischemic stroke at five-years (odds ratio, 1·2; 95% confidence interval, 1·02-1·42), and in the large-artery disease subtype (odds ratio, 1·46; 95% confidence interval, 1·12-1·91), but not in the other stroke subtypes (cardioembolic: odds ratio, 1·18; 95% confidence interval, 0·84-1·65; small-artery disease: odds ratio, 1·24; 95% confidence interval, 0·87-1·76; other subtype: odds ratio, 0·79; 95% confidence interval, 0·48-1·31). The probability of stroke recurrence increased in patients with large-artery disease and DL, compared with other subtypes of stroke [log rank test (Mantel-Cox) P < 0·013].
CONCLUSIONS: Our results showed that DL is related to the recurrent strokes in patients with ischemic stroke within five-years after ischemic stroke, specifically to the large-artery disease subtype.
© 2014 World Stroke Organization.

Entities:  

Keywords:  cardioembolic stroke; large-artery disease; lipids; small-artery disease; stroke recurrence

Mesh:

Substances:

Year:  2014        PMID: 25088494     DOI: 10.1111/ijs.12341

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  3 in total

1.  Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE).

Authors:  Martin J O'Donnell; Matthew McQueen; Allan Sniderman; Guillaume Pare; Xingyu Wang; Graeme J Hankey; Sumathy Rangarajan; Siu Lim Chin; Purnima Rao-Melacini; John Ferguson; Denis Xavier; Liu Lisheng; Hongye Zhang; Prem Pais; Patricio Lopez-Jaramillo; Albertino Damasceno; Peter Langhorne; Annika Rosengren; Antonio L Dans; Ahmed Elsayed; Alvaro Avezum; Charles Mondo; Conor Judge; Hans-Christoph Diener; Danuta Ryglewicz; Anna Czlonkowska; Nana Pogosova; Christian Weimar; Romana Iqbal; Rafael Diaz; Khalid Yusoff; Afzalhussein Yusufali; Aytekin Oguz; Ernesto Penaherrera; Fernando Lanas; Okechukwu S Ogah; Adesola Ogunniyi; Helle K Iversen; German Malaga; Zvonko Rumboldt; Shahram Oveisgharan; Fawaz Al Hussain; Yongchai Nilanont; Salim Yusuf
Journal:  J Stroke       Date:  2022-05-31       Impact factor: 8.632

2.  Values of serum LDL and PCT levels in evaluating the condition and prognosis of acute cerebral infarction.

Authors:  Xianliang Meng; Renying Wen; Xiao Li
Journal:  Exp Ther Med       Date:  2018-07-25       Impact factor: 2.447

3.  Modelling the prognostic effect of glucose and lipid profiles on stroke recurrence in Malaysia: an event-history analysis.

Authors:  Xin Wee Chen; Mohd Nazri Shafei; Zariah Abdul Aziz; Norsima Nazifah Sidek; Kamarul Imran Musa
Journal:  PeerJ       Date:  2020-02-14       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.